Edgestream Partners, L.P.
Position in CRL — Charles River Laboratories International, Inc.
CIK 1535061
Princeton, NJ
Position in CRL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,458,630
+$899,920 QoQ
Shares Held
10,841
+20.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#186
of 569 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Edgestream Partners, L.P. holds $7,616,279 across 5 Diagnostics & Research names. CRL ranks #1 (32.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
This page
|
10,841 | $2,458,630 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
1,863 | $2,380,001 | |
| 3 | LH |
Labcorp Holdings Inc.
|
5,885 | $1,647,800 | |
| 4 | TWST |
Twist Bioscience Corp
|
5,992 | $616,456 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
1,024 | $513,392 |
All Filings in CRL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,458,630 | 10,841 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,558,710 | 9,036 | Shares | Sole | 2026-05-18 | |
| 2025-09-30 | $4,172,318 | 26,667 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,797,545 | 11,847 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $2,377,648 | 12,880 | Shares | Sole | 2025-02-07 | |
| 2024-06-30 | $3,455,050 | 16,725 | Shares | Sole | 2024-08-09 | |
| 2021-12-31 | $3,644,216 | 9,672 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,711,755 | 4,148 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||